These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30903274)

  • 1. Feasibility of entirely subcutaneous ICD™ systems in patients with coronary artery disease.
    Willy K; Bettin M; Reinke F; Bögeholz N; Ellermann C; Rath B; Leitz P; Köbe J; Eckardt L; Frommeyer G
    Clin Res Cardiol; 2019 Nov; 108(11):1234-1239. PubMed ID: 30903274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the entirely subcutaneous ICD in borderline indications.
    Willy K; Reinke F; Bögeholz N; Köbe J; Eckardt L; Frommeyer G
    Clin Res Cardiol; 2020 Jun; 109(6):694-699. PubMed ID: 31586219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of entirely subcutaneous ICD™ systems in patients with dilated cardiomyopathy.
    Willy K; Reinke F; Bögeholz N; Ellermann C; Rath B; Köbe J; Eckardt L; Frommeyer G
    J Cardiol; 2020 May; 75(5):567-570. PubMed ID: 31744658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome differences and device performance of the subcutaneous ICD in patients with and without structural heart disease.
    Willy K; Reinke F; Bögeholz N; Ellermann C; Rath B; Leitz P; Köbe J; Eckardt L; Frommeyer G
    Clin Res Cardiol; 2020 Jun; 109(6):755-760. PubMed ID: 31667624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The entirely subcutaneous ICDTM system in patients with congenital heart disease: experience from a large single-centre analysis.
    Willy K; Reinke F; Bögeholz N; Köbe J; Eckardt L; Frommeyer G
    Europace; 2019 Oct; 21(10):1537-1542. PubMed ID: 31302706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long-Term Follow-Up.
    Rudic B; Tülümen E; Berlin V; Röger S; Stach K; Liebe V; El-Battrawy I; Dösch C; Papavassiliu T; Akin I; Borggrefe M; Kuschyk J
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spotlight on S-ICD™ therapy: 10 years of clinical experience and innovation.
    Bögeholz N; Willy K; Niehues P; Rath B; Dechering DG; Frommeyer G; Kochhäuser S; Löher A; Köbe J; Reinke F; Eckardt L
    Europace; 2019 Jul; 21(7):1001-1012. PubMed ID: 30887039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.
    Bettin M; Larbig R; Rath B; Fischer A; Frommeyer G; Reinke F; Köbe J; Eckardt L
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1499-1506. PubMed ID: 29759830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arrhythmia, device interventions and mortality analysis in patients with implanted cardioverter-defibrillator with/without resynchronisation therapy in dilative cardiomyopathy in primary prevention of sudden cardiac death].
    Lelakowski J; Pudło J; Lelakowska-Pieła M; Rydlewska A; Piekarz J; Domaracki D
    Pol Merkur Lekarski; 2016 Apr; 40(238):216-22. PubMed ID: 27137820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up of the first patients with a totally subcutaneous ICD in Germany from implantation till battery depletion.
    Bettin M; Rath B; Ellermann C; Leitz P; Reinke F; Köbe J; Eckardt L; Frommeyer G
    Clin Res Cardiol; 2019 Jan; 108(1):16-21. PubMed ID: 29948287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific indications and clinical outcome in patients with subcutaneous implantable cardioverter-defibrillator (ICD) - A nationwide multicentre registry.
    Sponder M; Khazen C; Dichtl W; Fiedler L; Mörtl D; Teubl A; Steinwender C; Martinek M; Nürnberg M; Dalos D; Kastner J; Schukro C
    Eur J Intern Med; 2018 Feb; 48():64-68. PubMed ID: 28978409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of appropriate implantable cardioverter-defibrillator therapy during long-term follow-up of patients with coronary artery disease.
    Blumer J; Wolber T; Hellermann J; Holzmeister J; Binggeli C; Duru F; Brunckhorst C
    Int Heart J; 2009 May; 50(3):313-21. PubMed ID: 19506335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitfalls of the S-ICD therapy: experiences from a large tertiary centre.
    Willy K; Reinke F; Rath B; Ellermann C; Wolfes J; Bögeholz N; Köbe J; Eckardt L; Frommeyer G
    Clin Res Cardiol; 2021 Jun; 110(6):861-867. PubMed ID: 33130912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Subcutaneous Cardioverter Defibrillator in Patients at High Risk of Sudden Cardiac Death　- Primary Japanese Experience.
    Sasaki S; Tomita H; Tsurugi T; Ishida Y; Shoji Y; Nishizaki K; Kinjo T; Endo T; Nishizaki F; Hanada K; Sasaki K; Horiuchi D; Kimura M; Higuma T; Okamatsu H; Tanaka Y; Koyama J; Okumura K
    Circ J; 2018 May; 82(6):1546-1551. PubMed ID: 29643282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
    Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
    JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-pharmacologic prevention of sudden cardiac death].
    Jurkovicová O; Cagán S
    Bratisl Lek Listy; 1997; 98(7-8):423-39. PubMed ID: 9471337
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.